Human Muse Cells Reconstruct Neuronal Circuitry in Subacute Lacunar Stroke Model

Stroke

Volumn 48, Issue 2, 2017, Pages 428-435

  Uchida, Hiroki ^a   Niizuma, Kuniyasu ^a   Kushida, Yoshihiro ^a   Wakao, Shohei ^a   Tominaga, Teiji ^a   Borlongan, Cesario V ^b   Dezawa, Mari ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

brain ischemia; cerebral infarction; regeneration; stem cells; stroke, lacunar

Indexed keywords

MICROTUBULE ASSOCIATED PROTEIN 2; NEURON SPECIFIC NUCLEAR PROTEIN;

ALU SEQUENCE; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; GOLGI COMPLEX; HUMAN; HUMAN CELL; LACUNAR STROKE; MALE; MITOCHONDRION; MOTOR CORTEX; MOUSE; MULTILINEAGE DIFFERENTIATING STRESS ENDURING CELL; NERVE CELL; NERVE CELL DIFFERENTIATION; NEURITE; NONHUMAN; PRIORITY JOURNAL; PYRAMIDAL TRACT; SPINAL CORD VENTRAL HORN; STEM CELL; STEM CELL TRANSPLANTATION; ANIMAL; BRAIN; CELL LINEAGE; CYTOLOGY; DISEASE MODEL; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMA CELL; NERVE CELL NETWORK; PATHOLOGY; PHYSIOLOGY; PROCEDURES; SCID MOUSE; STROKE, LACUNAR; TRANSGENIC MOUSE;

ANIMALS; BRAIN; CELL LINEAGE; DISEASE MODELS, ANIMAL; HUMANS; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MICE; MICE, SCID; MICE, TRANSGENIC; NERVE NET; STROKE, LACUNAR;

EID: 85007268676     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.116.014950     Document Type: Article

References (30)

1. Sudlow CL, Warlow CP. Comparable studies of the incidence of stroke and its pathological types: results from an international collaboration. International Stroke Incidence Collaboration. Stroke. 1997;28:491-499.
2. Jackson C, Sudlow C. Comparing risks of death and recurrent vascular events between lacunar and non-lacunar infarction. Brain. 2005;128(pt 11):2507-2517. doi: 10.1093/brain/awh636.
3. Norrving B. Long-term prognosis after lacunar infarction. Lancet Neurol. 2003;2:238-245.
4. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995;333:1581-1587.
5. Bliss TM, Andres RH, Steinberg GK. Optimizing the success of cell transplantation therapy for stroke. Neurobiol Dis. 2010;37:275-283. doi: 10.1016/j.nbd.2009.10.003.
6. Chen J, Li Y, Wang L, Zhang Z, Lu D, Lu M, et al. Therapeutic beneft of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats. Stroke. 2001;32:1005-1011.
7. Chen J, Zhang ZG, Li Y, Wang L, Xu YX, Gautam SC, et al. Intravenous administration of human bone marrow stromal cells induces angio-genesis in the ischemic boundary zone after stroke in rats. Circ Res. 2003;92:692-699. doi: 10.1161/01.RES.0000063425.51108.8D.
8. Parr AM, Tator CH, Keating A. Bone marrow-derived mesenchymal stro-mal cells for the repair of central nervous system injury. Bone Marrow Transplant. 2007;40:609-619. doi: 10.1038/sj.bmt.1705757.
9. Honmou O, Houkin K, Matsunaga T, Niitsu Y, Ishiai S, Onodera R, et al. Intravenous administration of auto serum-expanded autologous mes-enchymal stem cells in stroke. Brain. 2011;134(pt 6):1790-1807. doi: 10.1093/brain/awr063.
10. Abe K, Yamashita T, Takizawa S, Kuroda S, Kinouchi H, Kawahara N. Stem cell therapy for cerebral ischemia: from basic science to clinical applications. J Cereb Blood Flow Metab. 2012;32:1317-1331. doi: 10.1038/jcbfm.2011.187.
11. Kuroda Y, Kitada M, Wakao S, Nishikawa K, Tanimura Y, Makinoshima H, et al. Unique multipotent cells in adult human mesenchymal cell populations. Proc Natl Acad Sci U S A. 2010;107:8639-8643. doi: 10.1073/ pnas.0911647107.
12. Wakao S, Kitada M, Kuroda Y, Shigemoto T, Matsuse D, Akashi H, et al. Multilineage-differentiating stress-enduring (Muse) cells are a primary source of induced pluripotent stem cells in human fbroblasts. Proc Natl Acad Sci U S A. 2011;108:9875-9880. doi: 10.1073/pnas.1100816108.
13. Kuroda Y, Wakao S, Kitada M, Murakami T, Nojima M, Dezawa M. Isolation, culture and evaluation of multilineage-differentiating stress-enduring (Muse) cells. Nat Protoc. 2013;8:1391-1415. doi: 10.1038/ nprot.2013.076.
14. Katagiri H, Kushida Y, Nojima M, Kuroda Y, Wakao S, Ishida K, et al. A distinct subpopulation of bone marrow mesenchymal stem cells, muse cells, directly commit to the replacement of liver components. Am J Transplant. 2016;16:468-483. doi: 10.1111/ajt.13537.
15. Kinoshita K, Kuno S, Ishimine H, Aoi N, Mineda K, Kato H, et al. Therapeutic potential of adipose-derived SSEA-3-positive muse cells for treating diabetic skin ulcers. Stem Cells Transl Med. 2015;4:146-155. doi: 10.5966/sctm.2014-0181.
16. Yamauchi T, Kuroda Y, Morita T, Shichinohe H, Houkin K, Dezawa M, et al. Therapeutic effects of human multilineage-differentiating stress enduring (MUSE) cell transplantation into infarct brain of mice. PLoS One. 2015;10:e0116009. doi: 10.1371/journal.pone.0116009.
17. Uchida H, Morita T, Niizuma K, Kushida Y, Kuroda Y, Wakao S, et al. Transplantation of unique subpopulation of fbroblasts, muse cells, ameliorates experimental stroke possibly via robust neuronal differentiation. Stem Cells. 2016;34:160-173. doi: 10.1002/stem.2206.
18. Richel DJ, Johnsen HE, Canon J, Guillaume T, Schaafsma MR, Schenkeveld C, et al. Highly purifed CD34+ cells isolated using magnetically activated cell selection provide rapid engraftment following high-dose chemotherapy in breast cancer patients. Bone Marrow Transplant. 2000;25:243-249. doi: 10.1038/sj.bmt.1702136.
19. Uchida H, Sakata H, Fujimura M, Niizuma K, Kushida Y, Dezawa M, et al. Experimental model of small subcortical infarcts in mice with long-lasting functional disabilities. Brain Res. 2015;1629:318-328. doi: 10.1016/j.brainres.2015.10.039.
20. Hayase M, Kitada M, Wakao S, Itokazu Y, Nozaki K, Hashimoto N, et al. Committed neural progenitor cells derived from genetically modi-fed bone marrow stromal cells ameliorate deficits in a rat model of stroke. J Cereb Blood Flow Metab. 2009;29:1409-1420. doi: 10.1038/ jcbfm.2009.62.
21. Ogura F, Wakao S, Kuroda Y, Tsuchiyama K, Bagheri M, Heneidi S, et al. Human adipose tissue possesses a unique population of pluripotent stem cells with nontumorigenic and low telomerase activities: potential implications in regenerative medicine. Stem Cells Dev. 2014;23:717-728. doi: 10.1089/scd.2013.0473.
22. Bersano A, Ballabio E, Lanfranconi S, Boncoraglio GB, Corti S, Locatelli F, et al. Clinical studies in stem cells transplantation for stroke: a review. Curr Vasc Pharmacol. 2010;8:29-34.
23. Aboody KS, Brown A, Rainov NG, Bower KA, Liu S, Yang W, et al. Neural stem cells display extensive tropism for pathology in adult brain: evidence from intracranial gliomas. Proc Natl Acad Sci U S A. 2000;97:12846-12851. doi: 10.1073/pnas.97.23.12846.
24. Acosta SA, Tajiri N, Hoover J, Kaneko Y, Borlongan CV. Intravenous bone marrow stem cell grafts preferentially migrate to spleen and abrogate chronic infammation in stroke. Stroke. 2015;46:2616-2627. doi: 10.1161/STROKEAHA.115.009854.
25. Janowski M, Wagner DC, Boltze J. Stem cell-based tissue replacement after stroke: factual necessity or notorious fction? Stroke. 2015;46:2354-2363. doi: 10.1161/STROKEAHA.114.007803.
26. Heo JS, Choi SM, Kim HO, Kim EH, You J, Park T, et al. Neural trans-differentiation of human bone marrow mesenchymal stem cells on hydrophobic polymer-modifed surface and therapeutic effects in an animal model of ischemic stroke. Neuroscience. 2013;238:305-318. doi: 10.1016/j.neuroscience.2013.02.011.
27. Yasuhara T, Matsukawa N, Hara K, Maki M, Ali MM, Yu SJ, et al. Notch-induced rat and human bone marrow stromal cell grafts reduce ischemic cell loss and ameliorate behavioral deficits in chronic stroke animals. Stem Cells Dev. 2009;18:1501-1514. doi: 10.1089/scd.2009.0011.
28. Shen LH, Li Y, Chen J, Zacharek A, Gao Q, Kapke A, et al. Therapeutic beneft of bone marrow stromal cells administered 1 month after stroke. J Cereb Blood Flow Metab. 2007;27:6-13. doi: 10.1038/sj.jcbfm.9600311.
29. Bang OY, Lee JS, Lee PH, Lee G. Autologous mesenchymal stem cell transplantation in stroke patients. Ann Neurol. 2005;57:874-882. doi: 10.1002/ana.20501.
30. Battistella V, de Freitas GR, da Fonseca LM, Mercante D, Gutflen B, Goldenberg RC, et al. Safety of autologous bone marrow mononuclear cell transplantation in patients with nonacute ischemic stroke. Regen Med. 2011;6:45-52. doi: 10.2217/rme.10.97.